Bloomberg Businessweek
All Eyes on Gilead
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:20:10
- Mas informaciones
Informações:
Sinopsis
Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.
